WASHINGTON — The Coalition for a Prosperous America (CPA) today released a new academic report that details how a loophole in the Hatch-Waxman Act has led to generic drug shortages in the U.S., offshoring of America’s domestic production of generic pharmaceuticals to China and India, and price gouging by foreign companies in the U.S. The…
Both houses of Congress have bills that have passed committees, easily, in regard to building domestic supply of personal protective equipment for medical staff. These bills need to hit the floor so President Biden can sign them. But, more importantly, Buy American provisions face serious WTO risk, making all of this action moot.
How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
A Senate hearing today looked back at our early response to the pandemic. A year later, what went right, what went wrong, and how to re-shore pharma now.
Healthcare panelist and Phlow CEO Eric Edwards on what needs to be done to make more pharmaceutical drugs here. Most of them are coming in from Europe, India and…increasingly…China.
Rosemary Gibson chairs the healthcare committee of the Coalition for a Prosperous America. She is the author of “China Rx: Exposing the Risks of America’s Dependence on China for Medicine.” Over the past year, the COVID-19 pandemic has claimed many American lives. Millions are still out of work. This is the public toll of the…
WASHINGTON—A broad coalition of industry organizations and labor unions, representing a broad spectrum of manufacturers and workers who stepped up to make essential PPE and other products throughout the COVID-19 pandemic, sent a letter today to President Biden and congressional leaders outlining recommendations on specific policy initiatives that must be adopted to re-establish a permanent…